• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

New lubricant eye drop launched

Article

A new lubricant eye drop (Systane Balance, Alcon Laboratories) has been launched for patients with meibomian gland dysfunction.

Huenenberg, Switzerland-A new lubricant eye drop (Systane Balance, Alcon Laboratories) has been launched for patients with meibomian gland dysfunction.

The drop contains hydroxypropyl guar, borate, sorbitol, propylene glycol, and a proprietary emulsion technology (LipiTech System, Alcon) of mineral oil and an anionic phospholipid. It is available without a prescription at retailers in the United States and will be available in Latin America later this year.

“Meibomian gland dysfunction is a significant cause of dry eye symptoms and now patients who suffer from dry eye associated with meibomian gland dysfunction can use [the new drop] to restore their lipid layer, re-establish their natural tear film, and maintain their tear film stability,” said Sabri Markabi, MD, Alcon’s chief medical officer and senior vice president of research and development.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.